Table 1.

Distribution of demographic, clinical, and comorbid characteristics by statin treatment after diagnosis with HCC

VariablesCategoryTotal (n = 1,036)Statins after HCC diagnosis (n = 363)No statins after HCC diagnosis (n = 673)P
ncolumn%ncolumn%ncolumn%
Age0.0022
65–7455353.416746.038657.4
75–8439638.216144.423534.9
85+878.4359.6527.7
Sex0.0021
Male66664.325670.541060.9
Female37035.710729.526339.1
Race0.65
White60858.720757.040159.6
Black797.6277.4527.7
Other34933.712935.522032.7
Neighborhood median income0.087
<$35,00026825.98724.018126.9
$35,000–$49,99930929.89626.521331.7
$50,000–$74,99932331.212534.419829.4
$75,000+13613.15515.28112.0
Grade0.15
1 or 240138.715542.724636.6
3 or 4939.0318.5629.2
Unknown54252.317748.836554.2
Tumor size and stage0.013
Stage I, <5 cm34533.311030.323534.9
Stage II, <5 cm23923.17620.916324.2
Stage I/II, ≥5 cm38036.715743.322333.1
Stage I/II, unknown size727.0205.5527.7
Resection14914.45715.79213.70.37
Radiofrequency ablation16315.75816.010515.60.87
TACE35534.312735.022833.90.72
Transplantation666.4143.9527.70.015
CVD prior49848.121459.028442.2<0.0001
Cirrhosis50648.813737.736954.8<0.0001
Obesity/morbid obesity0.015
Neither93490.231486.562092.1
Obese676.5328.8355.2
Morbidly obese353.4174.7182.7
Dyslipidemia61859.725670.536253.8<0.0001
Diabetes54052.121860.132247.90.0002
Hypertension71969.426171.945868.10.20
Hepatitis B11711.33810.57911.70.54
Hepatitis C30729.67019.323735.2<0.0001